Meeting News Coverage

WINTHER trial seeks to select rational therapeutics based on analysis of tumor without DNA structural changes

HemOnc Today, August 10, 2013
PARIS – WINTHER, the first global clinical trial conducted by the WIN Consortium, is designed to fulfill the promise of personalized cancer…
Meeting News Coverage

WINTHER trial seeks to select rational therapeutics based on analysis of tumor without DNA structural changes

July 12, 2013
PARIS – WINTHER, the first global clinical trial conducted by the WIN Consortium, is designed to fulfill the promise of personalized cancer…
Meeting News Coverage

IMRT plus chemotherapy offers high locoregional control in advanced nasopharyngeal carcinoma

HemOnc Today, August 10, 2013
PARIS — Treatment with intensity-modulated radiotherapy and concurrent weekly chemotherapy improved xerostomia and dysphagia in patients with…
Meeting News Coverage

IMRT plus chemotherapy offers high locoregional control in advanced nasopharyngeal carcinoma

July 11, 2013
PARIS — Treatment with intensity-modulated radiotherapy and concurrent weekly chemotherapy improved xerostomia and dysphagia in patients with…
Meeting News Coverage

Comprehensive genome sequencing should be considered for advanced cancers to identify actionable gene mutations

HemOnc Today, August 10, 2013
PARIS — Patients with advanced/refractory cancers who are candidates for clinical trials could benefit from efforts to identify eligibility for…
Meeting News Coverage

Comprehensive genome sequencing should be considered for advanced cancers to identify actionable gene mutations

July 11, 2013
PARIS — Patients with advanced/refractory cancers who are candidates for clinical trials could benefit from efforts to identify eligibility for…
Meeting News Coverage

Local reactivity, biomarkers predict response to autologous melanoma vaccine

HemOnc Today, August 10, 2013
PARIS — The intensity of delayed-type hypersensitivity response predicted better survival among patients with macroscopic stage IIIB-C melanoma…
Meeting News Coverage

Local reactivity, biomarkers predict response to autologous melanoma vaccine

July 11, 2013
PARIS — The intensity of delayed-type hypersensitivity response predicted better survival among patients with macroscopic stage IIIB-C melanoma…
Meeting News Coverage

ER-positive, PR-positive breast cancer linked to increased risk for secondary primary cancer

HemOnc Today, August 10, 2013
Women with early-stage breast cancer whose disease was ER-positive and PR-positive were at significantly increased risk for developing secondary…
Meeting News Coverage

ER-positive, PR-positive breast cancer linked to increased risk for secondary primary cancer

July 11, 2013
Women with early-stage breast cancer whose disease was ER-positive and PR-positive were at significantly increased risk for developing secondary…